Close X
Wednesday, November 27, 2024
ADVT 
Health

'Ebola vaccine showing promising results'

Darpan News Desk IANS, 02 Dec, 2014 12:49 PM
    Two Ebola vaccines undergoing clinical trials have shown promising results and would be deployed in January 2015 to West African countries affected by the epidemic, a scientist from Oxford University said Monday.
     
    Speaking at a conference of African Immunologists in Nairobi, Adrian Hill, director of Oxford University's Jenner Institute, said the two vaccines will re-energise the fight against Ebola, Xinhua reported.
     
    "The two vaccines have demonstrated remarkable efficacy and have no side effects to Ebola patients. We anticipate their deployment will commence in January," Hill told African medical researchers.
     
    The World Health Organisation (WHO) Nov 29 revealed that 6,928 people have died of Ebola in Liberia, Guinea and Sierra Leone.
     
    At the same time, 16,000 people are infected with the Ebola virus and could succumb to death in the absence of proper treatment and care.
     
    Pharmaceutical giants, rich governments, foundations and multilateral agencies have contributed funds to support development of an Ebola vaccine.
     
    Hill said that clinical trials on Ebola vaccine have accelerated thanks to adequate funding and political attention.
     
    "Development of an Ebola vaccine is accelerating faster than anticipated. The vaccine is being tested in Mali where 80 people have received the jab," Hill said, adding that over 200 people have been vaccinated against Ebola globally.
     
    The clinical trials on Ebola vaccine commenced in September and the WHO will approve it once it passes efficacy and safety test.
     
    Hill revealed that pharmaceutical giants, British and American governments have collaborated to develop the Ebola vaccine.
     
    Clinical trials on Ebola vaccine have involved primates since the disease was discovered in 1976 in the Democratic Republic of Congo.
     
    "There was a breakthrough in the clinical trials targeting monkeys and the next phase will focus on the vaccines` efficacy on humans," Hill told scientists.
     
    He emphasised the vaccine will be a game changer in the war against Ebola in West and Central Africa.
     
    "The vaccine will be availed to high risk groups like health workers and people involved in burials," Hill said. 

    MORE Health ARTICLES

    Mother's viral infection may trigger diabetes in kids

    Mother's viral infection may trigger diabetes in kids
    The exact cause of juvenile diabetes had eluded scientists for long and researchers have now found that a mother's exposure to viruses...

    Mother's viral infection may trigger diabetes in kids

    Family meals protect kids from obesity

    Family meals protect kids from obesity
    Even having as few as one or two family meals a week during adolescence may protect your kids from being obese when they turn into adults, says a study....

    Family meals protect kids from obesity

    Teenagers' sense of invalidation linked to suicide risk

    Teenagers' sense of invalidation linked to suicide risk
    Independent of other known risk factors, measuring the sense of family or peer invalidation - or lack of acceptance - that teenagers harbour can...

    Teenagers' sense of invalidation linked to suicide risk

    Spine loss common in schizophrenia, bipolar disorder

    Spine loss common in schizophrenia, bipolar disorder
    Schizophrenia and bipolar disorder appear to be linked with dendritic spine loss in the brain, suggesting the two disorders may share common pathophysiological elements....

    Spine loss common in schizophrenia, bipolar disorder

    Pathway between brain and blood pressure identified

    Pathway between brain and blood pressure identified
    In a finding that may lead to improved treatments for hypertension and heart failure, scientists have uncovered a new pathway through which the brain...

    Pathway between brain and blood pressure identified

    Common painkiller may treat ageing lungs

    Common painkiller may treat ageing lungs
      Researchers have found that ibuprofen, a non-steroidal anti-inflammatory painkiller, could reduce lung inflammation associated with ageing....

    Common painkiller may treat ageing lungs